Cholera, the scourge of the Victorian era, is staging a comeback fuelled by conflict and climate breakdown. In 2024, there were 804,721 cholera cases and 5,805 deaths,according to the World Health Organization, a near 50% increase from the 535,321 cases and 4,007 deaths in 2023.Numbers have been surgingsince 2021 and scientists say official figures are probably very conservative. Theyestimate between 1.3m and 4m cases, and a range of21,000 to 143,000 deathsfrom cholera globally each year.Already in 2025, six countries – Myanmar, the Democratic Republic of the Congo, Sudan, South Sudan, Angola and Ghana – haverequested dosesfrom the global stockpile of cholera vaccines to help contain outbreaks.The stockpile is supposed to hold 5m doses, but a flood of requests, and reliance on a single supplier of cholera vaccines, left it totally depleted at some points in 2024. The high demand for emergency supplies has meant no preventive vaccine drives in high-risk countries since 2022.Inside a cholera wardThe scene at a cholera treatment unit (CTU) in Gurei, on the outskirts of the South Sudanese capital, Juba, is typical. At the doorway of a large tent, staff wearing full protective gear spray the feet of anyone willing to enter. Inside, everything is white and the smell of chlorine is in the air. The unit can accommodate 10 cholera patients on two rows of beds made of plastic material with a hole pierced in the middle, to enable the sick to relieve themselves into buckets placed underneath.It’s very hard to control cholera when you’re in the middle of a war … That’s where vaccines can be most helpfulAllyson Russell, epidemiologistPeople get cholera after exposure to a bacteria, usually by drinking contaminated water. Sufferers develop acute, watery diarrhoea. The first line of treatment is rehydration salts, dissolved in water for patients to drink. Some severe cases will need IV fluids, and antibiotics can be given to curtail the illness and limit symptoms.The Gurei CTU was set up by Médecins Sans Frontières (MSF) last November and needed to double its capacity in mid-January. Guta Epulo, the nurse activities manager overseeing the unit, says 217 people have been treated successfully, with no deaths: “But deaths have been reported in the community.”People fleeing the war in Sudan into South Sudan brought cholera into overcrowded camps, where poor sanitation and lack of access to clean water led to the disease spreading rapidly. As people from South Sudan returned home across the country, cholera moved with them, and seven out of 10 states have been affected.Saber Juma, 33, from Jebel Timan, developed cholera symptoms the day after his wife, Hawati Ajong, 27, had recovered and been discharged from the CTU.View image in fullscreenNurse Pamela Emmanuel with Hawati Ajong, left, and Saber Juma who have now recovered, at the MSF cholera treatment unit in Gurei, Juba, last week“In the morning, he was about to go to work. He took tea, and then he went to the bathroom three times,” she says. “Then he started vomiting and couldn’t move.”After two days of care, he is being discharged and will return to work picking through rubbish, which is “the only way I can get money”, he says. Many people in Jebel Timan believe the nearby dump is the source of the cholera outbreak, although Ajong highlighted the lack of clean water.“We are drinking the water from a well dug in the ground. I think the problem is coming from this water,” she says.Albino Diari Wornyang, 39, a pastor in Jebel Timani, lost his stepbrother to cholera on 13 January. “It started at 3am, and he died at 3pm,” he says.Vaccination seems to be bringing the outbreak under control in South Sudan, he says, but he is still worried. There is only one privately owned borehole serving several thousand people, and filling a 20-litre jerry can costs 1,500 SSP (about 25p). Alternatively, people can fetch water from a dug well, for 500 SSP, but it’s not entirely fenced and animals may come and drink there if no one is there to chase them away. The only free option is the unsafe water from the stream.Vaccine shortagesAfrica Centres for Disease Control and Prevention (Africa CDC) highlighted cholera as a significant killer on the continentduring a January 2025 briefing. Chief of staff, Prof Ngashi Ngongo, says outbreaks frequently resulted in high death rates because of “the weak health system with the quality of care and the lack of the key supplies that are needed to provide quality care”.He says the drivers are increased flooding related to the climate crisis, combined with poor water and sanitation conditions.View image in fullscreenAlbino Diari Wornyang, right, with his neighbour Justin Pasi Major, next to an unsafe dug well used by the communityNgongo also says a lack of cholera vaccines inAfricais a key challenge, adding that Africa CDC wants to accelerate plans to manufacture them on the continent.Allyson Russell, an epidemiologist and a senior programme manager in the high impact outbreaks team atGavi, the vaccine allianceresponsible for the global stockpile, says supply is “in a better place now than we were a few years ago”.A rise in cases since 2022 has “put a lot of strain on health systems, health workers, vaccine, supply, everything”, she says, adding: “Westarted off the year with the stockpile full.”It can also now be fully replenished in three or four weeks, she says, down from two months last year.skip past newsletter promotionSign up toGlobal DispatchFree newsletterGet a different world view with a roundup of the best news, features and pictures, curated by our global development teamEnter your email addressSign upPrivacy Notice:Newsletters may contain info about charities, online ads, and content funded by outside parties. For more information see ourPrivacy Policy. We use Google reCaptcha to protect our website and the GooglePrivacy PolicyandTerms of Serviceapply.after newsletter promotionView image in fullscreenMSF and health ministry staff visit Jebel Timan, a cholera hotspot in Juba, last weekEuBiologics in South Korea is the only company supplying the stockpile. It is now making a simplified version of itscholera vaccine, approved by the WHO in 2024, and has increased manufacturing capacity. “The combination of those two things has really increased the production. Last year, we delivered 40m doses for 40 million people, which is the highest number ever. This year, we’re aiming to have about 70 million,” Russell says.Russell stresses the importance of clean water and sanitation as the first line of defence, but adds: “It’s very hard to control cholera when you’re in the middle of a war, when there’s conflict, people are moving … That’s where vaccines can be most helpful.”Sami Ahmed, 35, is one of hundreds of cholera survivors in Sawakin, in eastern Sudan, where he fled from his home in Omdurman, the twin city of Khartoum. Some relatives, also displaced by conflict, lost their children in the rainy season cholera outbreak last August.“Almost in every household somebody had cholera in Sawakin … for the first time in my life I had it, I lost 40kg of my weight,” he says.An influx of people displaced by the civil war, coupled with limited toilets, has meant people in Sawakin being forced to defecate in the open.A bad smell pervades the city and in September Ahmed says armies of flies attacked it and Port Sudan, the de facto capital since the outbreak of war. “It was unbearable and I have never experienced such a thing in my life,” he says.View image in fullscreenThe dump in the Jebel Timan neighbourhood in Juba is a cholera hotspotRapid testing and preventative campaignsNewrapid testsfor cholera, which provide answers in about 15 minutes, are being introduced by Gavi to 14 low and middle income countries, and experts say they should give a clearer picture of where to focus control efforts.Gavi has also launched aplan to create a stable cholera vaccine supply, including preventive vaccination campaigns in vulnerable regions that should create confirmed and predictable demand.“It doesn’t make it very attractive for manufacturers if we don’t know [for] next year [or] especially in five years: how many vaccines do we need? What kind of manufacturing facility should be set up to support that?” Russell says. She adds that three high-priority countries – Bangladesh, DRC and Mozambique – have been approved for roll out when supplies allow.Prof Jan Holmgren of the University of Gothenburg led the team thatdeveloped the firstWHO approved oral cholera vaccine, Dukoral, in the 1990s. In recent years he has repeatedly said that a shortage of vaccine is “the most acute threat” to WHO’s aim of ending cholera by 2030.Cholera now threatens 1bn people. It’s time to finish what we began in the 19th centuryRead moreAmid shortages in October 2022, the International Coordinating Group (ICG), which manages the oral cholera vaccine emergency stockpile, announced that it could be used as a single dose vaccine, rather than two doses about two weeks apart.For Holmgren, the decision was “a step of despair”. While there is evidence that, in people who may have been previously exposed to cholera, a single dose can work as a form of booster jab, “younger children would absolutely need two doses in order to be protected”, he says.Early trialsin Bangladesh have shown that a single dose given to under-fives has no protective effect.Holmgren adds: “And if you also take this approach to populations which have not seen cholera frequently in the past, then one can assume that they will behave as young children in Bangladesh and not be protected by a single dose vaccine. So it’s obviously a risky approach.”Russell says the evidence so far is that the approach is proving effective at reducing spread of the disease in emergency settings, because it created herd immunity.Preventive vaccination campaigns will remain at two doses, however. “We know that this gives a longer protection, and that’s really the goal, especially in these endemic areas.”
Dirty water and endless wars: why cholera outbreaks are on the rise again
TruthLens AI Suggested Headline:
"Cholera Outbreaks Surge Amid Conflict and Climate Change Challenges"
TruthLens AI Summary
Cholera, a disease that plagued the Victorian era, is experiencing a resurgence driven by ongoing conflicts and climate change. In 2024, the World Health Organization reported 804,721 cholera cases and 5,805 deaths, marking a nearly 50% increase from the previous year. This upward trend has been evident since 2021, with estimates suggesting that the actual number of cases may range from 1.3 million to 4 million globally each year. Countries such as Myanmar, the Democratic Republic of the Congo, Sudan, South Sudan, Angola, and Ghana have already sought doses from a global cholera vaccine stockpile, which has been stretched thin due to high demand and reliance on a single supplier. The inability to conduct preventive vaccination drives in high-risk areas since 2022 has further exacerbated the situation, as communities grapple with the aftermath of conflict and the cumulative effects of climate-related disasters that have compromised water and sanitation infrastructure.
In South Sudan, cholera treatment units are struggling to keep up with the influx of patients as the disease spreads rapidly among displaced populations. Conditions in overcrowded camps, poor sanitation, and lack of access to clean water are contributing factors to the outbreaks. While vaccination efforts appear to be controlling the spread in some areas, the limited availability of clean water resources remains a significant concern. The Africa Centres for Disease Control and Prevention has highlighted cholera as a major health threat in Africa, attributing the high mortality rates to weak health systems and inadequate supplies. Efforts are underway to increase the manufacturing capacity of cholera vaccines, with new rapid testing methods being introduced to improve response times in affected regions. However, experts caution that the challenges posed by ongoing conflicts and ecological changes complicate efforts to eradicate cholera, underscoring the need for robust public health infrastructure and effective vaccination campaigns to protect vulnerable populations from this preventable disease.
TruthLens AI Analysis
The resurgence of cholera highlighted in this article points to broader issues related to global health, conflict, and climate change. The statistics presented indicate a dramatic increase in cholera cases and deaths, raising concerns about the capabilities of healthcare systems in crisis-stricken areas. This situation calls attention to the interconnectedness of environmental factors, social instability, and health outcomes.
Public Perception and Awareness
There is a deliberate effort to raise awareness about the alarming rise in cholera cases, particularly in conflict zones. This article aims to inform the public about the challenges faced in managing outbreaks when war and resource scarcity are prevalent. By showcasing the dire conditions in cholera treatment units, it evokes empathy and a sense of urgency among readers. The narrative suggests that without immediate intervention, the situation is likely to worsen, which can mobilize public support for global health initiatives and humanitarian aid.
Information Transparency
While the article presents alarming figures, it is crucial to scrutinize the potential underreporting of cholera cases and deaths. The acknowledgment that official numbers might be conservative hints at a broader issue: the need for better data collection and reporting in crisis-affected areas. This aspect of the article serves to highlight systemic failures in global health responses and encourages readers to demand accountability and improved health infrastructure.
Potential Omissions
The focus on cholera outbreaks might overshadow other concurrent health crises exacerbated by conflict and climate change. For instance, the article does not address how malnutrition or other infectious diseases could be affecting the same populations. This selective reporting could lead to a narrow understanding of the overall health landscape in these regions, suggesting that there are deeper issues that may be overlooked.
Manipulative Aspects
The article's emotional appeal, coupled with stark statistics, could be perceived as manipulative. By emphasizing the urgency and desperation within cholera wards, the piece may provoke a response from readers, potentially leading to calls for action without fully exploring the complexities of the situation. The language used is impactful, aiming to evoke strong feelings that could steer public opinion towards supporting specific health policies or interventions.
Comparative Context
When compared to other reports on global health crises, this article aligns with the growing trend of highlighting the impact of climate change and conflict on health. It taps into current discussions around public health as a critical component of global security and stability. The connection made between cholera, war, and environmental factors positions this issue within a larger narrative of global challenges, making it more relatable and urgent for readers.
Economic and Political Implications
The rise in cholera cases can have significant ramifications on local economies and political stability. Regions heavily affected by cholera outbreaks may experience increased healthcare costs, reduced productivity, and strained resources, exacerbating existing tensions. This could lead to a vicious cycle where economic hardship fuels further conflict, complicating humanitarian efforts.
Target Audience
The article likely appeals to a wide audience, including public health advocates, policymakers, and concerned citizens. By addressing the intersection of health and humanitarian crises, it reaches those interested in global issues and may galvanize support for interventions aimed at improving health outcomes in vulnerable populations.
Market Impact
While the article may not directly influence stock markets, it could have implications for companies involved in healthcare, pharmaceuticals, and humanitarian aid. Increased awareness of cholera outbreaks could lead to greater demand for vaccines and treatments, potentially benefiting companies in those sectors.
Global Power Dynamics
This discussion of cholera fits within the broader context of global health security, where nations are increasingly recognizing the importance of addressing health crises as part of geopolitical stability. The interplay between climate change, conflict, and health outcomes is becoming a focal point in international relations, possibly influencing foreign aid strategies and international cooperation. The article effectively highlights the urgent and complex relationship between cholera outbreaks, conflict, and climate change, pushing for more attention to these interconnected issues. The factual basis appears solid, given the reference to the World Health Organization data, but it is essential to consider the broader context and potential biases in the narrative presented.